BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25297701)

  • 1. Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
    Namikawa M; Kakizaki S; Kaira K; Tojima H; Yamazaki Y; Horiguchi N; Sato K; Oriuchi N; Tominaga H; Sunose Y; Nagamori S; Kanai Y; Oyama T; Takeyoshi I; Yamada M
    Hepatol Res; 2015 Sep; 45(9):1014-1022. PubMed ID: 25297701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
    Toyoda M; Kaira K; Ohshima Y; Ishioka NS; Shino M; Sakakura K; Takayasu Y; Takahashi K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Br J Cancer; 2014 May; 110(10):2506-13. PubMed ID: 24762957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
    Nikkuni O; Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Suzuki M; Iijima M; Asao T; Nishiyama M; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Pathol Oncol Res; 2015 Sep; 21(4):1175-81. PubMed ID: 26024742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.
    Kaira K; Arakawa K; Shimizu K; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
    Am J Transl Res; 2015; 7(2):356-63. PubMed ID: 25901202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma.
    Honjo H; Kaira K; Miyazaki T; Yokobori T; Kanai Y; Nagamori S; Oyama T; Asao T; Kuwano H
    J Surg Oncol; 2016 Mar; 113(4):381-9. PubMed ID: 26936531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinoma.
    Yazawa T; Shimizu K; Kaira K; Nagashima T; Ohtaki Y; Atsumi J; Obayashi K; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
    Am J Transl Res; 2015; 7(6):1126-39. PubMed ID: 26279756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.
    Kaira K; Nakamura K; Hirakawa T; Imai H; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Tsukamoto N; Oyama T; Asao T; Minegishi T
    Am J Transl Res; 2015; 7(6):1161-71. PubMed ID: 26279759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of amino acid transporter (LAT1 and 4F2hc) in pulmonary pleomorphic carcinoma.
    Kaira K; Kawashima O; Endoh H; Imaizumi K; Goto Y; Kamiyoshihara M; Sugano M; Yamamoto R; Osaki T; Tanaka S; Fujita A; Imai H; Kogure Y; Seki Y; Shimizu K; Mogi A; Shitara Y; Oyama T; Kanai Y; Asao T
    Hum Pathol; 2019 Feb; 84():142-149. PubMed ID: 30300664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.
    Kaira K; Sunose Y; Arakawa K; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
    Histopathology; 2015 Jan; 66(2):234-43. PubMed ID: 24845232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.
    Shimizu A; Kaira K; Kato M; Yasuda M; Takahashi A; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Asao T; Ishikawa O
    Melanoma Res; 2015 Oct; 25(5):399-405. PubMed ID: 26237765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
    Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
    Ogawa H; Kaira K; Motegi Y; Yokobori T; Takada T; Katoh R; Osone K; Takahashi R; Katayama C; Oyama T; Kanai Y; Yao T; Asao T; Kuwano H; Shirabe K
    Anticancer Res; 2019 May; 39(5):2535-2543. PubMed ID: 31092450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of L-type amino acid transporter 1 (LAT1) expression in patients with adenoid cystic carcinoma.
    Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Kanai Y; Oyama T; Chikamatsu K
    Pathol Oncol Res; 2013 Oct; 19(4):649-56. PubMed ID: 23516127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.
    Kaira K; Sunose Y; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Segawa A; Furuya M; Mori M; Oyama T; Takeyoshi I
    Br J Cancer; 2012 Aug; 107(4):632-8. PubMed ID: 22805328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.
    Shimizu K; Kaira K; Tomizawa Y; Sunaga N; Kawashima O; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Yamada M; Oyama T; Takeyoshi I
    Br J Cancer; 2014 Apr; 110(8):2030-9. PubMed ID: 24603303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer.
    Kaira K; Sunose Y; Ohshima Y; Ishioka NS; Arakawa K; Ogawa T; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Itoh H; Nagamori S; Kanai Y; Yamaguchi A; Segawa A; Ide M; Mori M; Oyama T; Takeyoshi I
    BMC Cancer; 2013 Oct; 13():482. PubMed ID: 24131658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of (S)-2-amino-3-[3-(2-
    Nozaki S; Nakatani Y; Mawatari A; Hume WE; Doi H; Watanabe Y
    EJNMMI Res; 2023 Apr; 13(1):36. PubMed ID: 37115356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Harmonious Interplay of Amino Acid and Monocarboxylate Transporters Induces the Robustness of Cancer Cells.
    Yoshida GJ
    Metabolites; 2021 Jan; 11(1):. PubMed ID: 33401672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas.
    Haining Z; Kawai N; Miyake K; Okada M; Okubo S; Zhang X; Fei Z; Tamiya T
    BMC Clin Pathol; 2012 Feb; 12():4. PubMed ID: 22373026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.